Global Transfection (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) Technologies (Lipofection, Calcium Phosphate, Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral) Market (2012 - 2017)

NEW YORK, Dec. 19, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p01057834/Global-Transfection-Gene-Delivery-DNA-Delivery-Protein-Delivery-SiRNA-Delivery-Technologies-Lipofection-Calcium-Phosphate-Electroporation-Nucleofection-Magnetofection-Gene-Gun-Viral-Market-2012-–-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genetically_Modified_Organism,_GMO

Transfection is an enabler technology used for many cell based research activities with applications spanning production of recombinant proteins and recombinant cell lines, gene therapy, delivery of therapeutics and also drug discovery. This research report provides a brief description on transfection technologies, its evolution, comparative analysis, market landscape analysis, competitive scenario and emerging technology and application trends. Global research and development Network, Innovation and Spin offs have been discussed. The report tracks regional adoption and development trends, providing strategic recommendation to stay active and compete in the market space. An impact analysis of major drivers and restraints influencing the growth of the market is mapped for five year period.

Cell research is a major driving factor for transfection market, as more than 60% of the users are of academic institutions and researchers. Research in gene transfer is being performed in in vivo conditions for different therapeutic applications; there is a growing demand for new transfection technologies to address unmet needs for therapeutic delivery which is driving the transfection market.

Key Restraint:

Home brewReagents restricts sale of commercial kits

Home brew reagents are still the preferred choice of reagents for transfection by researchers all over the world. Most of the researchers prepare their own reagents from their laboratory to conduct their research. This is true for most of the reagent based transfection reactions. This allows them to reduce cost involved in purchasing commercial kits.

Transfection is an enabler technology which is used in many cell research activities, however only few cell lines are majorly used in these experiments restricting the scope of the study. Transfection in hard to transfect cells is the need of hour and it is a major challenge. There are few upcoming transfection technologies like nucleofection and magnetofection – which are an off-shoot of electroporation, which have the potential to address these challenges but are currently cost prohibitive due to which the technologies may have a much slower uptake in the developing world.

The report also discusses new opportunities for investment in the upcoming areas like Gene therapy, Stem cell research and Electro-chemotherapy.

Different transfection technologies are analyzed through a multi-criteria based decision making process which provides competitive benchmarking. Further, the report analyses technology management strategies and technology road mapping for the forecast period. Profiles of over 20 Key companies in the area of Transfection technology sector have been provided. Key players include Life Technologies, Sigma Aldrich, Lonza, Promega, Qiagen, Bio-Rad, Roche, Polyplus Transfection, Mirius Bio, Maxcyte, etc.

1.1 Key Take-Aways

1.2 Report Scope

1.3 Research Methodology

1.4 Key Data Points From Secondary Sources

1.5 Key Data Points From Primary Sources

2. EXECUTIVE SUMMARY

3. TRANSFECTION TECHNOLOGIES – TECHNOLOGY LANDSCAPE ANALYSIS

3.1 Technology Overview (Introduction, Evolution and Market Segmentation)

3.2 Technology Value Chain Analysis (with Technology Capability/Maturity Levels)

3.3 Comparative Analysis Of Transfection Methods (Physical, biochemical and Viral)

3.4 Applications

3.4.1 Therapeutic delivery

3.4.1.1 Bio-Therpeutics (gene delivery, protein delivery)

3.4.1.2 ElectroChemotherapy and Electro-immunotherapy

3.4.2 Bio-Medical research

3.4.2.1 Transgenic models

3.4.2.2 Gene and protein expression studies

3.4.2.3 Cancer research

3.4.2.4 Cell based microarrays for drug discovery and development

3.4.3 Protein production (Recombinant protein, Vaccines)

4. TRANSFECTION - MARKET LANDSCAPE ANALYSIS 4.1 Global Market Forecast4.1.1 By Geography4.1.2 By Products4.1.3 By Application4.1.4 By Technology 4.2 Market Dynamics4.2.1 Drivers (with timeline)4.2.2 Restraints/Challenges (with timeline) 4.2.3 Emerging Trends

5. GLOBAL R&D PORTFOLIO ANALYSIS

5.1 Key R&D Networks – Current & Emerging – This segment will include university – Incubator divisions; company – VC funded corporate incubator divisions)

5.2 Universities With Potential Technologies For Licensing/Tech Transfer; Form Spin Offs

6. INVESTMENT/FUNDING ANALYSIS 6.1 Investment Climate Assessment 6.2 Investments On Transfection

7. TRANSFECTION – DIFFUSION ANALYSIS

7.1 Technology adoption and development-Geographical analysis

7.1.1 Introduction

7.1.2 North America

7.1.3 Europe

7.1.3.1 Key research areas based on Electroporation in European Union

7.1.3.2 Funding and development activities in European union

7.1.4 APAC

7.1.5 ROW

8. COMPETITIVE LANDSCAPE 8.1 Mergers & Acquisitions, 2007 – 20128.2 Partnerships & Collaborations, 2007 – 20128.3 New Product/Technology Development Initiatives 8.4 Market Share Analysis of Key Players - 2012

9. OPPORTUNITY EVALUATION AND TECHNOLOGY BENCHMARKING/ROADMAPPING

9.1 Scenario Modeling

9.2 Evaluation Of Emerging Opportunities

9.3 Technology Benchmarking Based On Multicriteria Decision Making

9.4 Technology Road mapping

10. PATENT ANALYSIS11. ANALYST INSIGHTS AND RECOMMENDATIONS 11.1 Introduction 11.2 Technology Management Strategies12. COMPANY PROFILES 12.1 LIFE TECHNOLOGIES CORPORATION12.2 LONZA GROUP LTD.12.3 PROMEGA CORPORATION12.4 SIGMA ALDRICH CORPORATION12.5 THERMO FISHER SCIENTIFIC INC.12.6 BIO-RAD LABORATORIES INC.12.7 ROCHE APPLIED SCIENCE12.8 QIAGEN N.V.,12.9 INOVIO PHARMACEUTICALS INC.,12.10 POLYPLUS TRANSFECTION S.A.12.11 MIRUS BIO LLC.12.12 CLONETECH LABORATORIES, INC.12.13 SIGNAGEN LABORATORIES12.14 MAXCYTE, INC.12.15 NANOTHERICS12.16 GENLANTIS12.17 TECHULON INC.,12.18 DELIVERICS LTD.12.19 OZ BIOSCIENCES12.20 MOLECULAR TRANSFER INC.,12.21 ALTOGEN BIOSYSTEMS 12.22 PROMOKINE GMBH

13. APPENDIX

14. GLOSSARY

List of Tables

TABLE 1 MAPPING OF TECHNOLOGY CAPABILITY AND MATURITY TABLE 2 GLOBAL TRANSFECTION MARKET REVENUE, 2012-2017 ($ MILLION) TABLE 3 GLOBAL TRANSFECTION MARKET BY GEOGRAPHY, 2012-2017 ($ MILLION) TABLE 4 GLOBAL TRANSFECTION MARKET REVENUE BY PRODUCTS, 2012-2017 ($ MILLION) TABLE 5 GLOBAL TRANSFECTION MARKET REVENUE BY APPLICATIONS 2012-2017 ($ MILLION) TABLE 6 GLOBAL TRANSFECTION MARKET REVENUE BY TECHNOLGY 2012-2017 ($ MILLION) TABLE 7 MARKET DYNAMICS - DRIVERS IMPACT TIME LINE TABLE 8 MARKET DYNAMICS - RESTRAINTS IMPACT TIMELINE TABLE 9 OPPORTUNITY STRATEGIC EVALUATION ANALYSIS

List of Figures

FIGURE 1 RESEARCH METHODOLOGYFIGURE 2 GLOBAL TRANSFECTION MARKET REVENUE, 2012-2017 ($ MILLION) FIGURE 3 TECHNOLOGY OVERVIEWFIGURE 4 TECHNOLOGY VALUE CHAIN ANALYSIS FIGURE 5 TECHNOLOGY CAPABILITY AND MATURITYFIGURE 6 TECHNOLOGY LIFE CYCLE ANALYSISFIGURE 7 GLOBAL TRANSFECTION MARKET REVENUE, 2012-2017 ($ MILLION) FIGURE 8 GLOBAL TRANSFECTION MARKET - GROWTH RATE BY GEOGRAPHY 2012 – 2017FIGURE 9 GLOBAL TRANSFECTION MARKET SHARE BY GEOGRAPHY 2012FIGURE 10 GLOBAL TRANSFECTION MARKET REVENUE BY GEOGRAPHY, 2012-2017 ($ MILLION)FIGURE 11 GLOBAL TRANSFECTION MARKET - GROWTH RATE BY PRODUCTS 2012 – 2017 FIGURE 12 GLOBAL TRANSFECTION MARKET SHARE BY PRODUCTS 2012FIGURE 13 GLOBAL TRANSFECTION MARKET REVENUE BY PRODUCTS, 2012-2017 ($ MILLION)FIGURE 14 GLOBAL TRANSFECTION MARKET - GROWTH RATE BY APPLICATIONS 2012 – 2017FIGURE 15 GLOBAL TRANSFECTION MARKET SHARE BY APPLICATIONS 2012FIGURE 16 GLOBAL TRANSFECTION MARKET REVENUE BY APPLICATIONS, 2012-2017($ MILLION) FIGURE 17 GLOBAL TRANSFECTION MARKET - GROWTH RATE BY TECHNOLOGY 2012 – 2017FIGURE 18 GLOBAL TRANSFECTION MARKET SHARE BY TECHNOLOGY 2012FIGURE 19 GLOBAL TRANSFECTION MARKET REVENUE BY TECHNOLOGY 2012-2017 ($ MILLION) FIGURE 20 GLOBAL RESEARCH PORTFOLIO-RESEARCH AND DEVELOPMENT NETWORKFIGURE 21 ATTRACTIVE FORCES FOR INCREASED MARKET VALUEFIGURE 22 ADOPTION RATE OF ELECTROCHEMOTHERAPY (2006-2010) FIGURE 23 FUNDING LANDSCAPE IN EUFIGURE 24 MARKET SHARE ANALYSIS OF KEY PLAYERS – 2012FIGURE 25 OPPORTUNITY STRATEGIC EVALUATION ANALYSIS FIGURE 26 PRIORITIZATION OF TRANSFECTION TECHNOLOGIES FOR FUTURE ADOPTIONFIGURE 27 PRIORITY VALUES FOR LEVEL 0 FIGURE 28 COMPARISON OF TECHNOLOGY BASED ON LEVEL 0 CRITERIA FIGURE 29 TECHNOLOGY PRIORITIZATION FIGURE 30 NO OF PATENTS PUBLISHED BETWEEN THE YEAR 2007-2012FIGURE 31 PERCENTAGE DISTRIBUTION: REAGENTS VS PHYSICAL (2007-2012)

To order this report:Genetically_Modified_Organism,_GMO Industry: Global Transfection (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) Technologies (Lipofection, Calcium Phosphate, Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral) Market (2012 – 2017)

Nicolas Bombourg

Reportlinker

Email: [email protected]

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker